Metrics as of 10/13/2026, 06:54 PM (Berlin time), refresh in progress.
Aurora Cannabis Inc.
Aurora Cannabis Inc. is a Canada-based firm specializing in the cultivation, processing, and global distribution of cannabis and its various derivative products. The company's operations encompass a broad spectrum of the cannabis industry, from facility engineering and design to genetic research, production, and the…
1D
-1.1%
1W
-5.2%
1M
+14.0%
6M
+18.4%
YTD
+4.7%
1Y
-21.5%
2Y
-19.9%
5Y
-93.1%
10Y
-97.6%
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~28% stronger price swings than usual
0
STRONG BUY
0
BUY
5
HOLD
2
SELL
0
STRONG SELL
7
TOTAL · Hold
As of: 17/12/2020
P/E
-3.13
P/B
0.71
EV/EBITDA
-4.16
RETURN ON EQUITY
-0.8%
NET MARGIN
-6.0%
DEBT/EQUITY
0.04
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
99.4%
FLOAT SHARES
61,543,239
AVG. DAILY VOLUME (30D)
339,106
Aurora Cannabis Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Miguel Martin, the company employs around 1,028 people.
The IPO was on 05/10/2016; the stock trades on TSX under the ticker ACB.TO.
7 analysts rate the stock, the consensus is Hold (as of 17/12/2020).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 28% stronger than usual.
No, Aurora Cannabis currently does not pay a dividend.
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Aurora Cannabis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.